美国宾州生物制药公司WINDTREETHERAPEUTICSINCWINT美股招股说明书S-12025-04-24版英文版63页.pdf

1、S-1/A 1 wint20250424_s1a.htm FORM S-1/ATable of ContentsAs filed with the Securities and Exchange Commission on April 24,2025 Registration No.333-284976 UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549 Amendment No.2toFORM S-1REGISTRATION STATEMENTUNDERTHE SECURITIES ACT OF 1933 W

2、INDTREE THERAPEUTICS,INC.(Exact name of registrant as specified in its charter)Delaware283694-3171943(State or other jurisdiction ofincorporation or organization)(Primary Standard IndustrialClassification Code Number)(I.R.S.EmployerIdentification No.)2600 Kelly Road,Suite 100Warrington,Pennsylvania

3、18976(215)488-9300(Address,including zip code,and telephone number,including area code,of registrants principal executive offices)Jed LatkinPresident and Chief Executive OfficerWindtree Therapeutics,Inc.2600 Kelly Road,Suite 100Warrington,Pennsylvania 18976(215)488-9300(Name,address including zip co

4、de,and telephone number,including area code,of agent for service)Copies to:Faith L.Charles,Esq.Thompson Hine LLP300 Madison Avenue,27th FloorNew York,New York 10017(212)344-5680Jamie McAndrewSenior Vice President and Chief Financial OfficerWindtree Therapeutics,Inc.2600 Kelly Road,Suite 100Warringto

5、n,Pennsylvania 18976(215)488-9300 Table of Contents Approximate date of commencement of proposed sale to the public:As soon as practicable after the effective date of thisRegistration Statement.If any of the securities being registered on this Form are to be offered on a delayed or continuous basis

6、pursuant to Rule 415under the Securities Act of 1933,check the following box.If this Form is filed to register additional securities for an offering pursuant to Rule 462(b)under the Securities Act,pleasecheck the following box and list the Securities Act registration statement number of the earlier